New study tracks Cancer's lasting impact on Women's sexual and fertility health
NCT ID NCT01788839
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 475 women with breast cancer or lymphoma to understand how their treatments affect sexual function and fertility. Participants complete questionnaires and may optionally provide blood samples to measure ovarian health. The goal is to learn about these long-term effects and what influences decisions about having children after cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Basking Ridge
RECRUITINGBasking Ridge, New Jersey, 07920, United States
-
Memorial Sloan Kettering Bergen
RECRUITINGMontvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Memorial Sloan Kettering Commack
RECRUITINGCommack, New York, 11725, United States
-
Memorial Sloan Kettering Monmouth
RECRUITINGMiddletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Nassau
RECRUITINGUniondale, New York, 11553, United States
-
Memorial Sloan Kettering Westchester
RECRUITINGHarrison, New York, 10604, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Could muscle loss predict blood cancer outcomes?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple